Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

HCC Profiles

Hepatocellular carcinoma (HCC) requires thorough evaluation of the tumor stage to ensure precise prognosis and clear treatment recommendations, including consideration of liver transplantation. To achieve this goal, patient assessment must be based on both radiological and clinical parameters. The new HCC staging support in mint Lesion™ 3.0 therefore allows to easily capture a number of relevant imaging parameters (e.g. size, number, vascular invasion) and clinical data (e.g. Child-Pugh score and Performance Status). Based on these parameters, mint Lesion™ 3.0 automatically derives BCLC and TNM staging as well as liver transplantation recommendations according to Milan or UCSF criteria.

 

Related Resources

Related Resources

4 Questions – 4 Answers // Imaging in Clinical Trials

Mint Medical, Inc. Vice President of Clinical Trials, Kelie Luby Discusses Advances in Imaging Analysis in Clinical Trials and What’s Next for Mint…

Joint partnership between Mint Medical and Siemens Healthineers syngo.via

Siemens Healthineers and Mint Medical joined forces to accelerate imaging and result reporting software availability in hospitals when and where it is…

Mint-Data for Personalized Medicine at Cancer Center in Tübingen/Germany

Compiling structured real-world-data from different medical disciplines, such as molecular genetics, laboratory medicine, pathology or radiology, to…